Results: 1-25 | 26-35
Results: 1-25/35
5 YEARS FOLLOW-UP OF A RANDOMIZED PLACEBO-CONTROLLED STUDY WITH FILGRASTIM (RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR) IN PATIENTS RECEIVING ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: HIRAOAKA A MASAOKA T SHIBATA H KASAI M MORIYAMA Y KATO S KODERA Y MATSUYAMA T HIRABAYASHI N KANAMARU A DOHY H SHIMOSAKA A TAKAKU F
Citation: A. Hiraoaka et al., 5 YEARS FOLLOW-UP OF A RANDOMIZED PLACEBO-CONTROLLED STUDY WITH FILGRASTIM (RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR) IN PATIENTS RECEIVING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 86(10), 1995, pp. 874-874
A LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL COMPARING INTERFERON-ALPHA WITH BUSULFAN FOR CHRONIC MYELOGENOUS LEUKEMIA
Authors: OHNISHI K TOMONAGA M KAMADA N ONOZAWA K KURAMOTO A DOHY H MIZOGUCHI H MIYAWAKI S TSUBAKI K MIURA Y OMINE M KOBAYASHI T NAOE T OHSHIMA T HIRASHIMA K OHTAKE S TAKAHASHI I MORISHIMA Y NAITO K ASOU N TANIMOTO M SAKUMA A OHNO R
Citation: K. Ohnishi et al., A LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL COMPARING INTERFERON-ALPHA WITH BUSULFAN FOR CHRONIC MYELOGENOUS LEUKEMIA, Leukemia research, 22(9), 1998, pp. 779-786
APPLICATION OF FLUORESCENCE IN-SITU HYBRIDIZATION TO DETECT RESIDUAL LEUKEMIC-CELLS WITH 9-22-TRANSLOCATIONS AND 15-17-TRANSLOCATIONS
Authors: TANAKA K ARIF M EGUCHI M KUMARAVEL TS UEDA R OHNO R IWATO K KYO T DOHY H KAMADA N
Citation: K. Tanaka et al., APPLICATION OF FLUORESCENCE IN-SITU HYBRIDIZATION TO DETECT RESIDUAL LEUKEMIC-CELLS WITH 9-22-TRANSLOCATIONS AND 15-17-TRANSLOCATIONS, Leukemia, 11(3), 1997, pp. 436-440
A RANDOMIZED TRIAL COMPARING INTERFERON-ALPHA WITH BUSULFAN FOR NEWLY-DIAGNOSED CHROMIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE
Authors: OHNISHI K OHNO R TOMONAGA M KAMADA N ONOZAWA K KURAMOTO A DOHY H MIZOGUCHI H MIYAWAKI S TSUBAKI K MIURA Y OMINE M KOBAYASHI T NAOE T OHSHIMA T HIRASHIMA K OHTAKE S TAKAHASHI I MORISHIMA Y NAITO K ASOU N TANIMOTO M SAKUMA A YAMADA K
Citation: K. Ohnishi et al., A RANDOMIZED TRIAL COMPARING INTERFERON-ALPHA WITH BUSULFAN FOR NEWLY-DIAGNOSED CHROMIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE, Blood, 86(3), 1995, pp. 906-916
A SPECIFIC CHROMOSOME ABNORMALITY OF T(4-12)(Q11-12-P13) IN CD7(-LEUKEMIA() ACUTE)
Authors: HARADA H ASOU H KYO T ASAOKU H IWATO K DOHY H ODA K HARADA Y KITA K KAMADA N
Citation: H. Harada et al., A SPECIFIC CHROMOSOME ABNORMALITY OF T(4-12)(Q11-12-P13) IN CD7(-LEUKEMIA() ACUTE), British Journal of Haematology, 90(4), 1995, pp. 850-854
BIPHASIC EXPRESSION OF CD4 IN ACUTE MYELOCYTIC-LEUKEMIA (AML) CELLS -AML OF MONOCYTE ORIGIN AND HEMATOPOIETIC PRECURSOR CELL ORIGIN
Authors: MIWA H MIZUTANI M MAHMUD N YAMAGUCHI M TAKAHASHI T SHIKAMI M SHIKU H TANAKA I NAKASE K NASU K DOHY H UEDA T KAMADA N KITA K
Citation: H. Miwa et al., BIPHASIC EXPRESSION OF CD4 IN ACUTE MYELOCYTIC-LEUKEMIA (AML) CELLS -AML OF MONOCYTE ORIGIN AND HEMATOPOIETIC PRECURSOR CELL ORIGIN, Leukemia, 12(1), 1998, pp. 44-51
CANCER INCIDENCE IN ATOMIC-BOMB SURVIVORS .3. LEUKEMIA, LYMPHOMA AND MULTIPLE-MYELOMA, 1950-1987
Authors: PRESTON DL KUSUMI S TOMONAGA M IZUMI S RON E KURAMOTO A KAMADA N DOHY H MATSUI T NONAKA H THOMPSON DE SODA M MABUCHI K
Citation: Dl. Preston et al., CANCER INCIDENCE IN ATOMIC-BOMB SURVIVORS .3. LEUKEMIA, LYMPHOMA AND MULTIPLE-MYELOMA, 1950-1987, Radiation research, 137(2), 1994, pp. 190000068-190000097
CHARACTERIZATION OF ACUTE-LEUKEMIA WITH T(4-12)
Authors: HARADA H HARADA Y EGUCHI M DOHY H KAMADA N
Citation: H. Harada et al., CHARACTERIZATION OF ACUTE-LEUKEMIA WITH T(4-12), Leukemia & lymphoma, 25(1-2), 1997, pp. 47
CLINICAL IMPORTANCE OF CD7 EXPRESSION IN ACUTE MYELOCYTIC-LEUKEMIA
Authors: KITA K MIWA H NAKASE K KAWAKAMI K KOBAYASHI T SHIRAKAWA S TANAKA I OHTA C TSUTANI H OGUMA S KYO T DOHY H KAMADA N NASU K UCHINO H
Citation: K. Kita et al., CLINICAL IMPORTANCE OF CD7 EXPRESSION IN ACUTE MYELOCYTIC-LEUKEMIA, Blood, 81(9), 1993, pp. 2399-2405
CLINICAL IMPORTANCE OF INTERLEUKIN-2 RECEPTOR ALPHA-CHAIN EXPRESSION IN ACUTE-LEUKEMIA
Authors: NAKASE K KITA K KAGEYAMA S TSUJI K MIYANISHI E MIWA H TANAKA I SHIRAKAWA S TANAKA I ANAZAWA H TSUTANI H KYO T DOHY H KAMADA N DOI S NASU K UCHINO H
Citation: K. Nakase et al., CLINICAL IMPORTANCE OF INTERLEUKIN-2 RECEPTOR ALPHA-CHAIN EXPRESSION IN ACUTE-LEUKEMIA, Cancer detection and prevention, 21(3), 1997, pp. 273-279
DETECTION OF RESIDUAL HOST-CELLS IN SEX-MISMATCHED BONE-MARROW TRANSPLANTATION IN VARIOUS HEMATOLOGICAL DISEASES BY FLUORESCENCE IN-SITU HYBRIDIZATION
Authors: ARIF M TANAKA K KUMARAVEL TS EGUCHI M IWATO K DOHY H KAMADA N
Citation: M. Arif et al., DETECTION OF RESIDUAL HOST-CELLS IN SEX-MISMATCHED BONE-MARROW TRANSPLANTATION IN VARIOUS HEMATOLOGICAL DISEASES BY FLUORESCENCE IN-SITU HYBRIDIZATION, Japanese journal of cancer research, 88(4), 1997, pp. 420-426
EMERGENCE OF KARYOTYPICALLY UNRELATED CLONE IN REMISSION OF DE-NOVO ACUTE MYELOBLASTIC LEUKEMIAS
Authors: KUDOH S ASOU H KYO T ASAOKU H DOHY H EGUCHI M TASHIRO S TANAKA K KAMADA N
Citation: S. Kudoh et al., EMERGENCE OF KARYOTYPICALLY UNRELATED CLONE IN REMISSION OF DE-NOVO ACUTE MYELOBLASTIC LEUKEMIAS, British Journal of Haematology, 89(3), 1995, pp. 531-534
EXPRESSION OF THE INTERLEUKIN-6 (IL-6), IL-6 RECEPTOR, AND GP130 GENES IN ACUTE-LEUKEMIA
Authors: INOUE K SUGIYAMA H OGAWA H YAMAGAMI T AZUMA T OKA Y MIWA H KITA K HIRAOKA A MASAOKA T NASU K KYO T DOHY H HARA J KANAMARU A KISHIMOTO T
Citation: K. Inoue et al., EXPRESSION OF THE INTERLEUKIN-6 (IL-6), IL-6 RECEPTOR, AND GP130 GENES IN ACUTE-LEUKEMIA, Blood, 84(8), 1994, pp. 2672-2680
FK506 FOR THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE IN PATIENTS WHO RECEIVED CYCLOSPORINE AS THE PROPHYLAXIS OR THERAPY
Authors: KANAMARU A HIRAOKA A DOHY H KODERA Y MORIYAMA Y OKAMOTO S MASAOKA T
Citation: A. Kanamaru et al., FK506 FOR THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE IN PATIENTS WHO RECEIVED CYCLOSPORINE AS THE PROPHYLAXIS OR THERAPY, Experimental hematology, 21(8), 1993, pp. 1067-1067
FK506 THERAPY FOR PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTERALLOGENIC BONE-MARROW TRANSPLANTATION
Authors: MASAOKA T HIRAOKA A KANAMARU A DOHY H KODERA Y MORIYAMA Y OKAMOTO S
Citation: T. Masaoka et al., FK506 THERAPY FOR PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTERALLOGENIC BONE-MARROW TRANSPLANTATION, Experimental hematology, 23(8), 1995, pp. 864-864
FK506 TREATMENT OF GRAFT-VERSUS-HOST DISEASE DEVELOPING OR EXACERBATING DURING PROPHYLAXIS AND THERAPY WITH CYCLOSPORINE AND OR OTHER IMMUNOSUPPRESSANTS/
Authors: KANAMARU A TAKEMOTO Y KAKISHITA E DOHY H KODERA Y MORIYAMA Y SHIBATA A KASAI M KATOH S SAITOH H MATSUDA T HATTORI M OKAMOTO S ASANO S HORIUCHI A HARADA M HIRAOKA A MASAOKA T
Citation: A. Kanamaru et al., FK506 TREATMENT OF GRAFT-VERSUS-HOST DISEASE DEVELOPING OR EXACERBATING DURING PROPHYLAXIS AND THERAPY WITH CYCLOSPORINE AND OR OTHER IMMUNOSUPPRESSANTS/, Bone marrow transplantation, 15(6), 1995, pp. 885-889
FREQUENT JUMPING TRANSLOCATIONS OF CHROMOSOMAL SEGMENTS INVOLVING THEABL ONCOGENE ALONE OR IN COMBINATION WITH CD3-MLL GENES IN SECONDARY LEUKEMIAS
Authors: TANAKA K ARIF M EGUCHI M KYO T DOHY H KAMADA N
Citation: K. Tanaka et al., FREQUENT JUMPING TRANSLOCATIONS OF CHROMOSOMAL SEGMENTS INVOLVING THEABL ONCOGENE ALONE OR IN COMBINATION WITH CD3-MLL GENES IN SECONDARY LEUKEMIAS, Blood, 89(2), 1997, pp. 596-600
HIDDEN MONOSOMY-7 IN ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROME DETECTED BY INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION
Authors: ARIF T TANAKA K DAMODARAN C ASOU H KYO T DOHY H KAMADA N
Citation: T. Arif et al., HIDDEN MONOSOMY-7 IN ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROME DETECTED BY INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION, Leukemia research, 20(9), 1996, pp. 709-716
HIGH-FREQUENCY OF RAS ONCOGENE MUTATION IN CHRONIC MYELOID-LEUKEMIA PATIENTS WITH MYELOBLASTOMA
Authors: TANAKA K TAKAUCHI K TAKECHI M KYO T DOHY H KAMADA N
Citation: K. Tanaka et al., HIGH-FREQUENCY OF RAS ONCOGENE MUTATION IN CHRONIC MYELOID-LEUKEMIA PATIENTS WITH MYELOBLASTOMA, Leukemia & lymphoma, 13(3-4), 1994, pp. 317-322
IDENTIFICATION OF A COMMONLY DELETED REGION AT 17P13.3 IN LEUKEMIA AND LYMPHOMA ASSOCIATED WITH 17P ABNORMALITY
Authors: SANKAR M TANAKA K KUMARAVEL TS ARIF M SHINTANI T YAGI S KYO T DOHY H KAMADA N
Citation: M. Sankar et al., IDENTIFICATION OF A COMMONLY DELETED REGION AT 17P13.3 IN LEUKEMIA AND LYMPHOMA ASSOCIATED WITH 17P ABNORMALITY, Leukemia, 12(4), 1998, pp. 510-516
IDENTIFICATION OF ILLEGITIMATE RECOMBINATION HOT-SPOT OF THE RETINOICACID RECEPTOR-ALPHA GENE INVOLVED IN 15,17-CHROMOSOMAL TRANSLOCATION OF ACUTE PROMYELOCYTIC LEUKEMIA
Authors: TASHIRO S KOTOMURA N TANAKA K SUZUKI K KYO T DOHY H NIWA O KAMADA N
Citation: S. Tashiro et al., IDENTIFICATION OF ILLEGITIMATE RECOMBINATION HOT-SPOT OF THE RETINOICACID RECEPTOR-ALPHA GENE INVOLVED IN 15,17-CHROMOSOMAL TRANSLOCATION OF ACUTE PROMYELOCYTIC LEUKEMIA, Oncogene, 9(7), 1994, pp. 1939-1945
INFLUENCE OF M-BCR BREAKPOINT SITES ON THE DURATION OF CHRONIC PHASE IN 100 PATIENTS WITH CHRONIC MYELOCYTIC-LEUKEMIA
Authors: TANAKA K HASHIMOTO T OGUMA N DOHY H KAMADA N
Citation: K. Tanaka et al., INFLUENCE OF M-BCR BREAKPOINT SITES ON THE DURATION OF CHRONIC PHASE IN 100 PATIENTS WITH CHRONIC MYELOCYTIC-LEUKEMIA, Cancer genetics and cytogenetics, 70(1), 1993, pp. 39-47
ISODICENTRIC CHROMOSOME-21 - A NOVEL ABERRATION IN ACUTE MYELOID-LEUKEMIA
Authors: SANKAR M TANAKA K ARIF M SHINTANI T KUMARAVEL TS KYO T DOHY H KAMADA N
Citation: M. Sankar et al., ISODICENTRIC CHROMOSOME-21 - A NOVEL ABERRATION IN ACUTE MYELOID-LEUKEMIA, Cancer genetics and cytogenetics, 107(1), 1998, pp. 69-72
JAPANESE B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - A CYTOGENETIC AND MOLECULAR BIOLOGICAL STUDY
Authors: ASOU H TAKECHI M TANAKA K TASHIRO S DOHY H OHNO R KAMADA N
Citation: H. Asou et al., JAPANESE B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - A CYTOGENETIC AND MOLECULAR BIOLOGICAL STUDY, British Journal of Haematology, 85(3), 1993, pp. 492-497
LONG-TERM FOLLOW-UP OF MINIMAL RESIDUAL DISEASE IN LEUKEMIA PATIENTS BY MONITORING WT1 (WILMS-TUMOR GENE) EXPRESSION LEVELS
Authors: INOUE K OGAWA H YAMAGAMI T SOMA T TANI Y TATEKAWA T OJI Y TAMAKI H KYO T DOHY H HIRAOKA A MASAOKA T KISHIMOTO T SUGIYAMA H
Citation: K. Inoue et al., LONG-TERM FOLLOW-UP OF MINIMAL RESIDUAL DISEASE IN LEUKEMIA PATIENTS BY MONITORING WT1 (WILMS-TUMOR GENE) EXPRESSION LEVELS, Blood, 88(6), 1996, pp. 2267-2278
Risultati: 1-25 | 26-35